Presence & RecognitionEvent: September 8, 2026
MyOme is hosting a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines and their implications for cardiovascular risk assessment with experts Akl Fahed, MD, MPH, and Michael Levin, MD.
Published
Signal category
Presence & Recognition
Quote
“Join us for a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines and their implications for cardiovascular risk assessment.”
— MyOme team
Company
MyOme
Empowering individuals to take control of their health through actionable genomic insights.
- Industry
- Biotechnology Research
- Location
- Palo Alto, US
- Company size
- 97 employees
Using whole genome sequencing and state-of-the-art bioinformatics, MyOme analyzes a single patient sample to produce comprehensive and clinically actionable reports that allow patients and their providers to make personalized lifestyle, prevention, and treatment choices.